类风湿关节炎患者使用肠外甲氨蝶呤的障碍与促进因素:范围综述
本范围综述检索了Medline、Embase、Scopus和Cochrane Library自建库至2021年5月的研究,纳入15项从成人类风湿关节炎患者视角探讨肠外甲氨蝶呤使用的研究。患者总体上对甲氨蝶呤注射满意,注射给药所需的灵巧性被视为障碍,而注射无明显疼痛被视为促进因素。患者通常偏好有助于自我给药的肠外甲氨蝶呤制剂,但多数研究集中于预充笔装置,且缺乏定性研究。
要点
- 患者总体上对甲氨蝶呤注射满意(情感态度)。
- 注射给药所需的灵巧性被视为障碍,注射无明显疼痛被视为促进因素。
- 患者通常偏好有助于自我给药的肠外甲氨蝶呤制剂。
核心结论
- 研究结果提示患者通常偏好具有促进自我给药属性的肠外甲氨蝶呤制剂,但多数已识别研究集中于预充笔装置,且存在显著研究空白如缺乏定性研究。
研究设计与样本
- 范围综述,检索Medline、Embase、Scopus和Cochrane Library自建库至2021年5月,纳入15项从成人类风湿关节炎患者视角探讨肠外甲氨蝶呤使用的任何类型研究,限英文。
主要发现
- 共纳入15项研究;涉及「情感态度」「负担」「干预一致性」和「自我效能」构念的研究最多,而「机会成本」和「感知有效性」构念很少报告,「道德性」构念未报告。
- 类风湿关节炎患者总体上对甲氨蝶呤注射满意(情感态度构念)。
- 在负担构念方面,注射给予甲氨蝶呤所需的灵巧性被视为障碍,而甲氨蝶呤注射无明显疼痛被视为促进因素。
局限性
- 多数已识别研究集中于预充笔装置。
- 存在显著研究空白,如缺乏定性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Methotrexate (MTX) is effective in controlling disease activity in rheumatoid arthritis (RA). Parenteral MTX may have benefits over oral MTX, but it is rarely used in practice. To better understand this low usage rate, it is necessary to explore the barriers and enablers of therapy from the perspective of RA patients. The objectives of this scoping review were to describe RA patients' perspectives on the barriers and enablers in the use of parenteral MTX and to identify the research gaps in this field. METHODS: The search was performed in Medline, Embase, Scopus, and Cochrane Library from inception to May 2021. Data synthesis was conducted using the Theoretical Framework of Acceptability. This scoping review included any type of study that explored the use of parenteral MTX by adult RA patients from the patients' perspective, written in English. RESULTS: Fifteen studies were included; findings related to the constructs "affective attitude," "burden," "intervention coherence," and "self-efficacy" were explored the most, while some were rarely ("opportunity cost" and "perceived effectiveness") or not ("ethicality") reported. RA patients were generally satisfied with MTX injections ("affective attitude"). From the burden construct, the requirement for dexterity for administering MTX by injection was considered a barrier, whereas the lack of significant pain from MTX injection was considered an enabler. CONCLUSION: The findings suggested that patients generally preferred parenteral MTX formulations with attributes that facilitate self-administration. However, much of the identified research focused on prefilled pen devices, and significant gaps were identified, such as a lack of qualitative research.
引用
- Tan JM, Reeve E, Fraser L, et al. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care Res (Hoboken). 2023. PMID: 37128818. doi:10.1002/acr.25141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。